Corcept Therapeutics (CORT) Non-Current Debt (2012 - 2016)
Corcept Therapeutics (CORT) posted Non-Current Debt of $3.7 million for Q2 2016, down 57.06% sequentially from $8.7 million in Q1 2016, and down 80.7% YoY from $19.4 million in Q3 2015.
Corcept Therapeutics (CORT) Non-Current Debt (2012 - 2016) Analysis & Trends
Corcept Therapeutics has reported Non-Current Debt for 5 years, with the latest figure at $3.7 million in Q2 2016.
- Quarterly Non-Current Debt fell 80.7% year-over-year to $3.7 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $3.7 million (down 80.7% YoY) and the FY2015 annual result came in at $12.5 million, down 48.79% from the prior year.
- Non-Current Debt eased to $3.7 million in Q2 2016 per CORT's latest filing, from $8.7 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $30.2 million in Q2 2013 and troughed at $3.7 million in Q2 2016.
- A 5-year average of $22.8 million and a median of $26.8 million in 2014 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2013 and 2016: Non-Current Debt advanced 6.41% in 2013, then plunged 80.7% in 2016.
- Over 5 years, Non-Current Debt stood at $29.0 million in 2012, then advanced by 1.01% to $29.3 million in 2013, then dropped by 16.57% to $24.5 million in 2014, then slumped by 48.79% to $12.5 million in 2015, then slumped by 70.11% to $3.7 million in 2016.
- According to Business Quant data, Non-Current Debt over the past three periods registered $3.7 million, $8.7 million, and $12.5 million for Q2 2016, Q1 2016, and Q4 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 3.74 Mn |
| Mar 31, 2016 | 8.72 Mn |
| Dec 31, 2015 | 12.53 Mn |
| Sep 30, 2015 | 16.13 Mn |
| Jun 30, 2015 | 19.40 Mn |
| Mar 31, 2015 | 22.13 Mn |
| Dec 31, 2014 | 24.46 Mn |
| Sep 30, 2014 | 25.99 Mn |
| Jun 30, 2014 | 27.64 Mn |
| Mar 31, 2014 | 28.22 Mn |
| Dec 31, 2013 | 29.32 Mn |
| Sep 30, 2013 | 30.14 Mn |
| Jun 30, 2013 | 30.24 Mn |
| Mar 31, 2013 | 28.90 Mn |
| Dec 31, 2012 | 29.03 Mn |
| Sep 30, 2012 | 28.33 Mn |